John G. Ullman & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.61M | Buy |
11,198
+203
| +2% | +$97.5K | 0.68% | 47 |
|
|
2026
Q1 | $5.4M | Sell |
10,995
-830
| -7% | -$450K | 0.72% | 46 |
|
|
2025
Q4 | $6.85M | Sell |
11,825
-265
| -2% | -$150K | 0.91% | 34 |
|
|
2025
Q3 | $5.86M | Buy |
12,090
+476
| +4% | +$222K | 0.79% | 38 |
|
|
2025
Q2 | $4.71M | Buy |
11,614
+2,671
| +30% | +$1.12M | 0.7% | 43 |
|
|
2025
Q1 | $4.45M | Sell |
8,943
-113
| -1% | -$61.2K | 0.69% | 46 |
|
|
2024
Q4 | $4.71M | Sell |
9,056
-4,339
| -32% | -$2.39M | 0.69% | 50 |
|
|
2024
Q3 | $8.29M | Sell |
13,395
-75
| -0.6% | -$44.4K | 1.19% | 21 |
|
|
2024
Q2 | $7.45M | Sell |
13,470
-85
| -0.6% | -$48.7K | 1.14% | 23 |
|
|
2024
Q1 | $7.88M | Sell |
13,555
-450
| -3% | -$253K | 1.21% | 22 |
|
|
2023
Q4 | $7.43M | Sell |
14,005
-623
| -4% | -$302K | 1.18% | 23 |
|
|
2023
Q3 | $7.4M | Sell |
14,628
-250
| -2% | -$133K | 1.21% | 21 |
|
|
2023
Q2 | $7.76M | Sell |
14,878
-266
| -2% | -$144K | 1.2% | 22 |
|
|
2023
Q1 | $8.73M | Sell |
15,144
-175
| -1% | -$98.6K | 1.36% | 20 |
|
|
2022
Q4 | $8.44M | Sell |
15,319
-225
| -1% | -$119K | 1.35% | 21 |
|
|
2022
Q3 | $7.88M | Sell |
15,544
-2,000
| -11% | -$1.12M | 1.38% | 22 |
|
|
2022
Q2 | $9.53M | Hold |
17,544
| – | – | 1.53% | 20 |
|
|
2022
Q1 | $10.4M | Sell |
17,544
-122
| -0.7% | -$70.1K | 1.44% | 26 |
|
|
2021
Q4 | $11.8M | Sell |
17,666
-125
| -0.7% | -$78K | 1.62% | 20 |
|
|
2021
Q3 | $10.2M | Sell |
17,791
-200
| -1% | -$110K | 1.38% | 27 |
|
|
2021
Q2 | $9.08M | Sell |
17,991
-140
| -0.8% | -$66.1K | 1.18% | 34 |
|
|
2021
Q1 | $8.28M | Sell |
18,131
-531
| -3% | -$253K | 1.11% | 35 |
|
|
2020
Q4 | $8.69M | Sell |
18,662
-89
| -0.5% | -$41.7K | 1.35% | 27 |
|
|
2020
Q3 | $8.28M | Sell |
18,751
-4,303
| -19% | -$1.78M | 1.71% | 21 |
|
|
2020
Q2 | $8.35M | Sell |
23,054
-150
| -0.6% | -$50.3K | 2.04% | 18 |
|
|
2020
Q1 | $6.58M | Sell |
23,204
-484
| -2% | -$153K | 1.75% | 19 |
|
|
2019
Q4 | $7.7M | Sell |
23,688
-1,169
| -5% | -$354K | 1.32% | 22 |
|
|
2019
Q3 | $7.24M | Sell |
24,857
-587
| -2% | -$168K | 1.32% | 25 |
|
|
2019
Q2 | $7.47M | Sell |
25,444
-500
| -2% | -$138K | 1.31% | 26 |
|
|
2019
Q1 | $7.1M | Sell |
25,944
-420
| -2% | -$105K | 1.29% | 26 |
|
|
2018
Q4 | $5.9M | Sell |
26,364
-386
| -1% | -$90.6K | 1.19% | 29 |
|
|
2018
Q3 | $6.53M | Sell |
26,750
-290
| -1% | -$66.7K | 1.19% | 30 |
|
|
2018
Q2 | $5.6M | Buy |
27,040
+1,932
| +8% | +$410K | 1.06% | 35 |
|
|
2018
Q1 | $5.18M | Sell |
25,108
-158
| -0.6% | -$33.2K | 1% | 36 |
|
|
2017
Q4 | $4.8M | Sell |
25,266
-200
| -0.8% | -$38.3K | 0.96% | 34 |
|
|
2017
Q3 | $4.82M | Sell |
25,466
-767
| -3% | -$139K | 0.94% | 40 |
|
|
2017
Q2 | $4.58M | Sell |
26,233
-100
| -0.4% | -$16.8K | 0.91% | 43 |
|
|
2017
Q1 | $4.04M | Sell |
26,333
-600
| -2% | -$91.7K | 0.84% | 42 |
|
|
2016
Q4 | $3.8M | Sell |
26,933
-484
| -2% | -$71.4K | 0.8% | 46 |
|
|
2016
Q3 | $4.36M | Sell |
27,417
-1,075
| -4% | -$166K | 0.9% | 40 |
|
|
2016
Q2 | $4.21M | Sell |
28,492
-334
| -1% | -$49.3K | 0.86% | 40 |
|
|
2016
Q1 | $4.08M | Sell |
28,826
-283
| -1% | -$37.9K | 0.96% | 33 |
|
|
2015
Q4 | $4.13M | Sell |
29,109
-1,424
| -5% | -$190K | 0.91% | 34 |
|
|
2015
Q3 | $3.73M | Sell |
30,533
-1,990
| -6% | -$259K | 0.89% | 36 |
|
|
2015
Q2 | $4.22M | Sell |
32,523
-1,610
| -5% | -$210K | 0.79% | 40 |
|
|
2015
Q1 | $4.58M | Sell |
34,133
-1,750
| -5% | -$226K | 0.87% | 34 |
|
|
2014
Q4 | $4.5M | Sell |
35,883
-67
| -0.2% | -$8.15K | 0.85% | 39 |
|
|
2014
Q3 | $4.38M | Sell |
35,950
-1,100
| -3% | -$134K | 0.84% | 36 |
|
|
2014
Q2 | $4.37M | Sell |
37,050
-900
| -2% | -$106K | 0.8% | 36 |
|
|
2014
Q1 | $4.56M | Sell |
37,950
-1,550
| -4% | -$184K | 0.85% | 37 |
|
|
2013
Q4 | $4.4M | Sell |
39,500
-950
| -2% | -$94.5K | 0.84% | 35 |
|
|
2013
Q3 | $3.73M | Sell |
40,450
-650
| -2% | -$58.8K | 0.76% | 41 |
|
|
2013
Q2 | $3.48M | Buy |
+41,100
| New | +$3.42M | 0.73% | 45 |
|
Other funds holding TMO
John G. Ullman & Associates's TMO Position: Q2 2026 in Review
John G. Ullman & Associates increased its Thermo Fisher Scientific (TMO) stake by 1.8% in Q2 2026, buying an estimated $97.5K and bringing the position to 11,198 shares worth $5.61M. The position accounts for 0.68% of the portfolio, ranked #47.
John G. Ullman & Associates first reported a position in TMO in Q2 2013 and has held it in 53 quarters since. The position peaked at $11.8M in Q4 2021. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.
- John G. Ullman & Associates held 11,198 shares of Thermo Fisher Scientific worth $5.61M as of Q2 2026.
- John G. Ullman & Associates bought 203 Thermo Fisher Scientific shares in Q2 2026, an estimated $97.5K.
- Thermo Fisher Scientific made up 0.68% of John G. Ullman & Associates's portfolio in Q2 2026, its #47 holding.
- John G. Ullman & Associates first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 53 quarters since.
- John G. Ullman & Associates's Thermo Fisher Scientific position peaked at $11.8M in Q4 2021.
- 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.
Based on John G. Ullman & Associates's 13F filing for Q2 2026, filed 11 Aug 2026.